Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)

Clinical trial NCT03502629 · UNKNOWN

Trial details

NCT number: NCT03502629
Sponsor: Genor Biopharma Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral T Cell Lymphoma

Start date: 2018-07-02
Primary completion: 2021-08-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.